A collision on a ski slope led to Liz Healy being diagnosed with two rare cancers. Two months later, she underwent a 10-hour ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...